OICHARTS
8 AMThe 8 AM report →

TAKE

TAKE Limited · NSE · INE142I01023 · 78 sessions on record
₹12.65▼ −0.66 · −5.0%from ₹13.31 the session before · 1 Oct 2026 close · NSE end of day
Open
₹12.65
High
₹12.65
Low
₹12.65
Day's range
₹0.000.00% of the previous close
VWAP
₹12.65close 0.00% from it
Volume, shares
1.4 L0.39× the 20-session average
Turnover, ₹ crore
0.18
Trades
340410 shares per trade
Previous close
₹13.31−0.66 to the close
Price band, next session
₹11.40 – ₹13.9010% either side of the close · dynamic, widened in 5% steps when hit
Day range0% of the way up
₹12.65₹12.65
52-week range5% of the way up
₹12.06 1 Oct₹24.39 13 Aug

−48% from the high · +4.9% from the low

Futures and options

No derivatives listed on TAKE

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up78 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close
78 sessions on file · from 9 Sept
TAKE close and futures open interest over the last 78 sessions, with Nifty 50 rebased to the first close8.8816.3223.76axis spans 168%Nifty 50TAKE9 Sept7 Aug1 Oct78 sessions from 9 Sept to 1 Oct; the price axis spans 168 percent.

Quarterly results

consolidated · latest filed 11 Aug, 06:37 pm IST · NSE filings

Revenue ₹30 cr; profit ₹1 cr in the Jun 2026 quarter, consolidated.

Last 2 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session
Quarterly results of TAKE on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue ₹ crRevenue YoYProfit ₹ crProfit YoYEPS ₹Market on the day
Jun 2026filed 11 Aug₹30 cr—₹1 cr—0.07▲ +1.3%Nifty −0.1% · +1.4 pp
Mar 2026filed 20 May · audited₹54 cr—₹4 cr—0.29—not reached

Fundamentals

consolidated · filings to Jun 2026 · close ₹12.65 on 1 Oct

6.0 times book value, market cap ₹190 cr.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
₹190 cron 1 Oct · free float ₹190 cr
Price to earnings
—fewer than four consecutive quarters filed
Trailing EPS
—fewer than four consecutive quarters filed
Price to book
6.0consolidated · balance sheet to Mar 2026
Book value a share
₹2.10consolidated · balance sheet to Mar 2026 · over NSE's share count
Debt to equity
0.00borrowings over equity · consolidated · balance sheet to Mar 2026
Return on equity
—needs two filed balance sheets
Dividend yield
—no dividend with an ex-date in 365 days
Face value
₹1a share
Shares outstanding
15 cron 1 Oct
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
—fewer than four consecutive quarters filed
Revenue growth, 12 months
—needs eight consecutive quarters filed
Revenue 3-year CAGR
—needs twelve consecutive quarters filed
Profit, trailing 12 months
—fewer than four consecutive quarters filed
Profit growth, 12 months
—needs eight consecutive quarters filed
Profit 3-year CAGR
—needs twelve consecutive quarters filed
PeersBSE sub-group Healthcare Research, Analytics & Technology · F&O stocks with filings on record · industry P/E needs two stocks with trailing profit and a market cap
Stocks in the BSE sub-group Healthcare Research, Analytics & Technology with market cap, price to earnings and price to book
StockMarket cap ₹P/EP/BClose ₹
SYNGENESyngene International Limited15,000 cron 1 Oct—3.0₹361.30
INDGNIndegene Limited14,000 cron 1 Oct—4.6₹593.50
SUVENSuven Life Sciences Limited8,700 cron 1 Oct—15₹308.30
VIMTALABSVimta Labs Limited2,600 cron 1 Oct—5.7₹584.35
TAKETAKE Limited190 cron 1 Oct—6.0₹12.65
BIBilcare Limited————

Shareholding

quarter to 30 Jun · none pledged · NSE filings

Foreign portfolio investors hold 0.2%, individual investors 30.8% and others 69.0%, as filed for the quarter to 30 Jun.

By category, last 2 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file
Shareholding of TAKE by category over the last 2 quarters with the change against the previous quarter
Category30 Jun31 Mar
Foreign portfolio investors0.20▼ −0.08 pp0.28
Individual investors30.80▼ −1.97 pp32.77
Bodies corporate19.26▲ +1.15 pp18.11
Others49.74▲ +0.89 pp48.85

Corporate actions

NSE and BSE records

Nothing upcoming on record; the last was a Annual General Meeting, ex-date 7 Aug 2024.

Actionsex-dates · upcoming first, then the last eight · dividends in rupees a share, bonus and split as ratios
Corporate actions of TAKE, upcoming first, then the most recent
Ex-dateActionAmount or ratioRecord dateSource
recent
7 Aug 2024otherAnnual General Meeting——NSE
Calendaras notified to the exchange
Next results
—no board meeting notified yet
Dividends in 365 days
—a share · ex-dates inside the year
Last dividend
—none on record

Price history

78 sessions on record · to 1 Oct · NSE end of day

TAKE is −8.7% over 20 sessions against Nifty's −6.2%, 48% below its 52-week high, realised volatility 73% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
WindowFrom ₹TAKE %Nifty 50 %Difference pp
60 sessionssince 3 Oct₹12.66▼ −0.08%▼ −9.9%+9.8
20 sessionssince 2 Sept₹13.86▼ −8.7%▼ −6.2%−2.5
5 sessionssince 24 Sept₹15.40▼ −18%▼ −2.8%−15
1 sessionsince 30 Sept₹13.31▼ −5.0%▼ −0.88%−4.1
Averages of the closeclose against each average
5-session average
₹14.04close −9.9% from it
20-session average
₹15.49close −18% from it
50-session average
₹18.61close −32% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹0.947.5% of the close
Average day's range, 20
₹0.483.8% of the close
Volume against 20 sessions
0.39×1.4 L vs 3.6 L average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
73%≈ ±4.6% a session · moved more than that on 14 of 20
Realised volatility, 60
66%≈ ±4.1% a session · moved more than that on 34 of 60
Beta to Nifty, 60
-0.74moved with Nifty on 32 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
10 up · 10 downof 20
Last 60 sessions
34 up · 26 downof 60
Best session, 250
▲ +12%20 Jul
Worst session, 250
▼ −5.0%26 Aug

0 bulletins on TAKE

The desk has not written about TAKE Limited yet. The tape carries every bulletin as it is published.

About TAKE Limited

exchange masters as of 18 Sept 2026 · classification by BSE
Company
TAKE Limited
Exchange
NSE · BSE 532890, group B
Listed on NSE
27 Aug 2007
Classification
Healthcare › Healthcare Services › Healthcare Research, Analytics & Technology
Face value
₹1 a share
ISIN
INE142I01023
Sessions on record
78
Price source
NSE UDiFF bhavcopy · end of day · delayed
Filings
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
2 Oct, 01:46 am IST
Bulletins
0 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.